Filing Details
- Accession Number:
- 0001214659-19-000676
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-31 19:00:14
- Reporting Period:
- 2019-01-29
- Accepted Time:
- 2019-01-31 19:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1370348 | A Craig Johnson | C/O Mirati Therapeutics Inc. 9393 Towne Centre Drive, Ste 200 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-29 | 7,000 | $15.79 | 7,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-29 | 10,000 | $3.65 | 17,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-29 | 8,475 | $61.11 | 8,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-29 | 8,525 | $61.80 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-01-29 | 7,000 | $0.00 | 7,000 | $15.79 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-01-29 | 10,000 | $0.00 | 10,000 | $3.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-11-07 | No | 4 | M | Direct | |
| 0 | 2027-05-16 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2018.
- This transaction was executed in multiple trades at prices ranging from $60.43 to $61.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $61.44 to $62.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 1/4th of the shares subject to the Option shall vest and become exercisable on September 4, 2014, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
- The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.
Billionaire Hedge Funds
